Panel Discussion

Current Trends and Challenges in Cancer Management

Followed by Interactive Q&A

 Discussion Focus Areas:

1. Evolving Trends in Cancer Care

• Personalized Medicine & Genomics:
  Targeted therapies and mutation-specific treatments (e.g., EGFR, HER2, BRAF).

• Immunotherapy Breakthroughs:
  Checkpoint inhibitors, CAR-T cells, bispecific antibodies.

• Integrative Oncology:
  Nutrition, stress management, exercise, and complementary therapies.

• Digital & AI Integration:
  In diagnosis (digital pathology), treatment planning, and patient monitoring.

• Minimally Invasive & Precision Techniques:
  Proton therapy, robotic surgeries, image-guided biopsies/interventions.

2. Challenges in Cancer Management

• Late Presentation and Diagnosis:
  Need for better screening and awareness, especially in low-resource settings.

• Access to Advanced Therapies:
  High cost and limited availability of novel drugs and technologies.

• Treatment Resistance & Recurrence:
  Emerging resistance to targeted therapies; managing refractory disease.

• Quality of Life & Survivorship:
  Long-term effects, fatigue, mental health, and rehabilitation.

• Multidisciplinary Coordination:
  Ensuring smooth integration of oncologists, radiologists, surgeons, palliative teams.

 Key Perspectives from the Panel:

• Oncologist’s Viewpoint: Precision, combination therapies, clinical trials.

• Surgical Oncologist’s Insight: Balancing curative and functional outcomes.

• Palliative Care Expert: Early integration of palliative strategies.

• Patient Advocate: Importance of communication, navigation, and empathy.

• Public Health Perspective: Policy, education, and equitable care delivery.

 Q&A Session Highlights:

• Addressing specific clinical dilemmas.

• Discussing real-world application of new therapies.

• Interactive discussion on ethical and practical issues (e.g., end-of-life care, over-treatment).

 Conclusion:

Cancer management is increasingly complex, yet more hopeful than ever. Bridging innovation with access, personalization with empathy, and curative intent with quality of life will shape the future of oncology.